National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 1) (PB 3 of 2020) (Cth)

PB 3 of 2020

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 1)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated    29^th January 2020

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2020 (No. 1).

(2)This Instrument may also be cited as PB 3 of 2020.

1. Commencement

This Instrument commences on 1 February 2020.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, omit entry for Lisdexamfetamine

1. Schedule 1, entry for Ranitidine

omit:

Tablet, effervescent, 150 mg (as hydrochloride) 20 60 5

1. Schedule 1, entry for Tiotropium

insert as first entry:

Capsule containing powder for oral inhalation 13 micrograms (as bromide) (for use in Zonda device) 20 30 5